Tobacco use, especially cigarette smoking, is a major risk factor for cardiovascular morbidity
and mortality and is the leading preventable cause of death worldwide. Comprehensive …

Cardiovascular morbidity and mortality as a result of inhaled tobacco products continues to
be a global healthcare crisis, particularly in low-and middle-income nations lacking the …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

This narrative review examines the impact of cigarette smoking and the use of other tobacco
and nicotine products on cardiovascular disease. Smoking increases the incidence of both …

Quality of life is an important indicator of the treatment process, lifestyle, and influence of
many other factors, both exogenous and endogenous, on the body. Determining the quality …

Aims The post-discharge outcomes of patients with cancer who undergo PCI are not well
understood. This study evaluates the rates of readmissions within 90 days for acute …

Background—Less than one-third of smokers hospitalized with an acute coronary syndrome
(ACS) remain abstinent following discharge. We assessed whether varenicline, begun in …

Aims To evaluate the long-term use of secondary prevention medications [statins, β-
blockers, renin–angiotensin–aldosterone system (RAAS) inhibitors, and platelet inhibitors] …

Background Smoking is a well-established risk factor for ST-segment elevation myocardial
infarction (STEMI); however, once STEMI occurs, smoking has been associated with …

Background Prior studies have found that smokers undergoing thrombolytic therapy for ST‐
segment elevation myocardial infarction have lower in‐hospital mortality than nonsmokers, a …